What's Happening?
The Texas Rangers have signed right-handed pitcher Declan Cronin, who previously played for the Miami Marlins. Cronin is known for his ability to strike out 9.2 batters per nine innings, although he has faced several injuries, including a knee injury in 2024, a hip problem in 2025, and an elbow surgery later that year. The Rangers are looking to the future with this signing, as Cronin is expected to miss the entire 2026 season due to Tommy John surgery. The contract terms have not been disclosed, but it is likely a two-year deal allowing Cronin to rehabilitate with the Rangers' training staff before returning to play in 2027.
Why It's Important?
This signing is significant for the Texas Rangers as they aim to bolster their pitching lineup for future seasons. Despite
Cronin's injury history, the Rangers see potential in his ability to strike out batters and are willing to invest in his recovery. This move reflects a strategic approach to building a strong pitching roster, potentially offering long-term benefits if Cronin can return to form. The decision also highlights the team's willingness to take calculated risks on players with high upside, which could pay off if Cronin successfully rehabilitates and contributes to the team's success in the coming years.
What's Next?
Cronin will spend the 2026 season focusing on rehabilitation from Tommy John surgery under the guidance of the Rangers' training staff. The team will monitor his progress closely, with the hope that he can return to the mound in 2027. The Rangers may also continue to explore other opportunities to strengthen their pitching staff, ensuring they have a competitive lineup for future seasons. Fans and analysts will be watching Cronin's recovery process, as his return could significantly impact the team's performance.
